Viewing Study NCT01303835

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-06-10 @ 6:08 PM
Study NCT ID: NCT01303835
Status: COMPLETED
Last Update Posted: 2015-07-17
First Post: 2011-02-23
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Low Dose Naltrexone for Glioma Patients
Sponsor: Katy Peters
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None malignant glioma View
None glioblastoma multiforme View
None quality of life View
None naltrexone View